SUSQUEHANNA INTERNATIONAL GROUP, LLP - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 41 filers reported holding SOLENO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$8,000
-11.1%
42,443
+4.1%
0.00%
Q1 2022$9,000
-94.5%
40,777
-89.9%
0.00%
Q4 2021$164,000
-50.2%
403,486
+13.0%
0.00%
Q3 2021$329,000
-31.5%
356,993
-15.3%
0.00%
Q2 2021$480,000
+122.2%
421,286
+145.6%
0.00%
Q1 2021$216,000
-21.2%
171,504
+20.9%
0.00%
Q4 2020$274,000
-25.9%
141,866
-3.9%
0.00%
Q3 2020$370,000
-6.8%
147,560
-17.5%
0.00%
Q2 2020$397,000
+115.8%
178,900
+131.2%
0.00%
Q1 2020$184,000
+283.3%
77,370
+377.7%
0.00%
Q4 2019$48,000
+65.5%
16,198
+0.0%
0.00%
Q4 2017$29,00016,1950.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$19,884,0006.80%
Trellus Management Company, LLC 662,612$1,279,0001.06%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$7,084,0000.89%
CVI Holdings, LLC 1,550,960$2,993,0000.56%
Nantahala Capital Management 7,871,356$15,192,0000.47%
AWM Investment Company, Inc. 1,550,000$2,991,0000.38%
SILVERARC CAPITAL MANAGEMENT, LLC 322,798$623,0000.36%
Granite Point Capital Management, L.P. 1,926,594$3,718,0000.19%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,758,200$11,113,0000.16%
Greylin Investment Management, Inc 113,195$218,0000.05%
View complete list of SOLENO THERAPEUTICS INC shareholders